Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis

Overview of attention for article published in Cochrane database of systematic reviews, April 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

blogs: 1 blog
twitter: 41 tweeters

facebook: 2 Facebook pages

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 32 Mendeley

Summary Blogs Twitter Facebook Dimensions citations

So far, Dimensions has found 2 publications that cite this research output.

2

The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.

Evaluation of Health-Related Values and Preferences of Adults Who Were Preterm Infants and Parents of Preterm Infants Concerning Use of Prophylactic Cyclooxygenase Inhibitor Drugs

Article in JAMA Network Open (March 2023)

In preterm or low birth weight infants, do cyclo-oxygenase inhibitors (COX-I) help prevent morbidity and mortality?

Article in Cochrane Clinical Answers (September 2022)